ArticleJAMA network open2026

GLP-1 Receptor Agonist Use and Survival Among Patients With Type 2 Diabetes and Brain Metastases.

Kuan-Yu Chi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.